Company Overview - Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company focused on addressing underserved conditions such as stress-induced psychiatric disorders, chronic pain, and central nervous system diseases [4] - The company's portfolio includes innovative programs targeting PTSD, fibromyalgia, chronic pain, Alzheimer's disease, and multiple sclerosis, developed in collaboration with leading universities and laboratories [4] Investment in DeSci - Silo Pharma has made an initial purchase of ResearchCoin (RSC), the native token of ResearchHub, as part of its strategy to expand its digital assets treasury and capture long-term value from emerging multi-chain opportunities [1][2] - The investment in RSC aligns with the growing decentralized science (DeSci) movement, which emphasizes the use of blockchain technologies and token-based economics to modernize scientific research and collaboration [2] DeSci Movement - DeSci represents a transformative growth opportunity in the scientific research sector, with the potential to unlock a trillion-dollar global research economy currently tied up in grants, universities, and pharmaceutical pipelines [3] - By tokenizing research funding and intellectual property, DeSci can create profit opportunities years before traditional biotech exits, allowing investors to capture upside earlier and access new growth avenues in the biotech sector [3]

Listing Update - Coinbase 将在 Base 网络上支持 ResearchCoin (RSC) [1] - RSC-USD 交易对预计于 2025 年 7 月 31 日太平洋时间上午 9 点开始分阶段进行，具体取决于流动性条件 [1] Project Background - ResearchHub 基金会创建 RSC，旨在激励科学家公开分享学术内容 [1]